Medicinal Cannabis Industry Australia (MCIA) and Epilepsy Action Australia (EAA) have teamed up to develop CanGuide, EAA’s independent service providing information on cannabis-based medicine to patients and healthcare practitioners.

The pair have signed a memorandum of understanding which will see them “collaborate and work together to support and develop CanGuide’s position as the source of trusted information on cannabis-based medicines”.

Carol Ireland - Cannabis News Australia - Cannabiz
Epilepsy Action Australia CEO Carol Ireland

MCIA chair Peter Crock said: “MCIA is delighted to partner with an organisation of EAA’s credibility, reputation and capability to deliver an information platform for patients, GPs and healthcare professionals. 

“A trusted information platform has been identified as a key area of need for the industry by prescribers and others. We hope this partnership will enable the industry to attract the funding required to develop and continue to enhance this valuable and much-needed resource.”

EAA CEO Carol Ireland added: “It is pleasing to have the support of the medicinal cannabis industry’s peak body to help take CanGuide to the next stage of development and… enable the wide distribution of educational material to GPs, healthcare professionals and consumers.”

The information will be delivered via the CanGuide website and the HealthShare platform, which is integrated into the clinical software of 90% of Australian GPs.

CanGuide will be demonstrated at the MCIA booth at next week’s ACannabis conference (March 14-15).

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment